US2002039778A1PendingUtilityA1
Isolated and purified DNA molecule and protein for the degradation of triazine compounds
Est. expiryOct 23, 2015(expired)· nominal 20-yr term from priority
C07K 16/40C12N 9/14B09C 1/10A62D 2101/26A62D 3/02
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Abstract of the Disclosure An isolated and purified DNA molecule, and an isolated and purified protein, that are involved in the degradation of s-triazine compounds (e.g., atrazine) are provided. A method for the purification of this protein is also provided.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An isolated and purified DNA molecule encoding atrazine chlorohydrolase; the DNA molecule hybridizes to DNA complementary to DNA having the sequence shown in FIG. 6 (SEQ ID NO:1), beginning at position 236 and ending at position 1655, under the stringency conditions of hybridization in buffer containing 0.25 M Na 2 HPO 4 , 7% SDS, 1% BSA, 1.0 mM EDTA at 65° C., followed by washing with 0.1% SDS and 0.1×SSC at 65° C.
2 . The isolated and purified DNA molecule of claim 1 encoding the atrazine chlorohydrolase having an amino acid sequence shown in FIG. 7 (SEQ ID NO:2).
3 . The isolated and purified DNA molecule of claim 1 having the nucleotide sequence shown in FIG. 6 (SEQ ID NO:1) beginning at position 236 and ending at position 1655.
4 . The isolated and purified DNA molecule of claim 1 having the nucleotide sequence shown in FIG. 6 (SEQ. ID NO:1).
5 . An isolated and purified protein having a molecular weight of about 245 kilodaltons that converts atrazine to hydroxyatrazine.
6 . The isolated and purified protein of claim 5 which is a homotetramer.
7 . The isolated and purified protein of claim 5 which has the amino acid sequence shown in FIG. 7 (SEQ. ID NO:2).
8 . The isolated and purified protein of claim 7 bound to an immobilization support.
9 . An isolated and purified protein encoded by the DNA molecule of claim 1 .
10 . An isolated and purified protein encoded by the DNA molecule of claim 3 .
11 . A polyclonal antibody preparation produced from the isolated and purified protein of claim 5 .
12 . A polyclonal antibody preparation produced from the isolated and purified protein of claim 7 .
13 . A vector comprising the DNA molecule of claim 1 .
14 . The vector of claim 13 wherein the DNA molecule of claim 1 is derived from a Pseudomonas strain.
15 . A non-Pseudomonas bacterial cell comprising the vector of claim 14 .
16 . An isolated and purified oligonucleotide of about 7-300 nucleotides which hybridizes to DNA having the sequence shown in FIG. 6 (SEQ ID NO:1), beginning at position 236 and ending at position 1655, under the stringency conditions of hybridization in buffer containing 0.25 M Na 2 HPO 4 , 7% SDS, 1% BSA, 1.0 mM EDTA at 65° C., followed by washing with 0.1% SDS and 0.1×SSC at 65° C.
17 . A method for the purification of atrazine chlorohydrolase in at least about 90% yield consisting of a step of adding ammonium sulfate to an aqueous cell-free extract of an atrazine chlorohydrolase-containing bacterium.
18 . The method of claim 17 wherein ammonium sulfate is added in an amount of no greater than about 20% of saturation.
19 . A method for the degradation of compounds have the following general formula:
wherein R 1 ═Cl, R 2 ═NR 4 R 5 (wherein R 4 and R 5 are each independently H or a C 1−3 alkyl group), and R 3 ═NR 6 R 7 (wherein R 6 and R 7 are each independently H or a C 1−3 alkyl group), with the proviso that at least one of R 2 or R 3 is an alkylamino group; said method comprising adding atrazine chlorohydrolase to a sample containing said compound.
20 . The method of claim 19 wherein the sample is a soil sample.
21 . The method of claim 20 wherein the soil sample is contaminated with a nitrogen-containing fertilizer.
22 . The method of claim 19 wherein the step of adding atrazine chlorohydrolase comprises adding a recombinant bacterium that expresses atrazine chlorohydrolase.
23 . The method of claim 19 wherein the step of adding atrazine chlorohydrolase comprises adding the bacterial cell of claim 15 .
24 . An isolated and purified protein that converts atrazine to hydroxyatrazine, wherein the protein comprises an amino acid sequence encoded by a DNA molecule having a compliment that hybridizes to a DNA having the sequence shown in FIG. 6 (SEQ ID NO:1), beginning at position 236 and ending at position 1655, under the stringency conditions of hybridization in buffer containing 0.25 M Na 2 HPO 4 , 7% SDS, 1% BSA, 1.0 mM EDTA at 65° C., followed by washing with 0.1% SDS and 0.1×SSC at 65° C.
25 . An isolated and purified protein and biologically active derivatives thereof that convert atrazine to hydroxyatrazine, wherein the protein comprises an amino acid sequence encoded by a DNA molecule having a compliment that hybridizes to a DNA having the sequence shown in FIG. 6 (SEQ ID NO:1), beginning at position 236 and ending at position 1655, under the stringency conditions of hybridization in buffer containing 0.25 M Na 2 HPO 4 , 7% SDS, 1% BSA, 1.0 mM EDTA at 65° C., followed by washing with 0.1% SDS and 0.1 ×SSC at 65° C.
26 . An isolated and purified protein that converts atrazine to hydroxyatrazine, wherein the protein comprises an amino acid sequence having greater than about 80% sequence identity to the amino acid sequence depicted at SEQ ID NO:2.
27 . An isolated and purified protein and biologically active derivatives thereof that convert atrazine to hydroxyatrazine, wherein the protein comprises an amino acid sequence having greater than about 80% sequence identity to the amino acid sequence depicted at SEQ ID NO:2.Join the waitlist — get patent alerts
Track US2002039778A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.